
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-03-04-2015
- Volume 11
- Issue 3
AmeriSourceBergen Adds New Distribution Center in Australia
The new center represents AmerisourceBergen’s first facility erected specifically for clinical trial and commercial third-party logistics activities.
AmerisourceBergen’s specialty logistics company World Courier announced on Feb. 11, 2015 that the company opened a new global distribution center in Melbourne, Australia. The new location will serve existing World Courier clinical trial clients as well as global manufacturers seeking to commercialize products in Australia.
The new facility will enable expanded patient access to time- and temperature-sensitive medications and will expand World Courier’s global reach, according to a release. World Courier has already “successfully piloted commercial 3PL in Australia” at another facility, according to John Butler, president of World Courier, and it is now capable of launching a nationwide effort through its collaboration with AmerisourceBergen.
“We’re taking World Courier’s local market knowledge and specialty logistics expertise and combining it with the supply chain and commercialization experience that AmerisourceBergen is renowned for in North America,” said Doug Cook, president of Global Specialty Logistics at AmerisourceBergen, in a statement. Since AmerisourceBergen purchased World Courier in 2012 for $520 million in cash, the companies have been working together to merge their collective talents, he added.
A statement from AmerisourceBergen in 2012 released shortly after the completion of the World Courier acquisition
Source:
AmerisourceBergen
Articles in this issue
over 11 years ago
Grand River Names Director of Manufacturingover 11 years ago
WellSpring Pharma Services Names New Presidentover 11 years ago
Repligen Expands US Manufacturing Facilityover 11 years ago
PBOA Supports Legislation to Protect FDA User Feesover 11 years ago
Novasep to Manufacture Celladon's Mydicar APIover 11 years ago
Modest Expectations for CMOs and Biosimilarsover 11 years ago
FDA Tightens Drug Security Regulationsover 11 years ago
Mitigating Cold-Chain Risksover 11 years ago
The Challenge of Resolving Agents for Chiral Resolutionover 11 years ago
Catalent Expands Clinical Packaging Capabilities in Europe



